Groupama Asset Managment Acquires 7,713 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Groupama Asset Managment boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 17.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 52,196 shares of the medical equipment provider's stock after buying an additional 7,713 shares during the period. Groupama Asset Managment's holdings in Intuitive Surgical were worth $256,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of ISRG. Mirador Capital Partners LP increased its stake in Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock valued at $1,732,000 after acquiring an additional 50 shares during the last quarter. Consolidated Planning Corp increased its stake in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock valued at $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider's stock valued at $39,622,000 after purchasing an additional 76,649 shares during the last quarter. Swiss National Bank lifted its position in shares of Intuitive Surgical by 0.3% during the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider's stock worth $517,209,000 after buying an additional 3,400 shares during the last quarter. Finally, ABLE Financial Group LLC bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth $604,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 0.1 %

ISRG stock traded down $0.77 during mid-day trading on Tuesday, reaching $538.09. The company's stock had a trading volume of 1,047,243 shares, compared to its average volume of 1,443,882. Intuitive Surgical, Inc. has a 12 month low of $309.80 and a 12 month high of $556.23. The business's 50 day moving average price is $517.16 and its 200 day moving average price is $475.65. The company has a market cap of $191.66 billion, a price-to-earnings ratio of 86.51, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Ratings Changes

ISRG has been the subject of several research analyst reports. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Raymond James increased their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research note on Monday, October 14th. Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a "buy" rating in a research note on Thursday, August 22nd. Leerink Partners increased their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $541.33.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company's stock, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,485 shares of company stock valued at $26,128,102. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.